RARA CRAFT DATABASE for FDA Medical Devices
510(k)K182442

FDA DEVICE FACTS

MiniGuard Arterial Safety Valve

Quest Medical, Inc.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATENovember 6, 2018PRODUCT CODEMJJ

Indications for use

The MiniGuard™ Arterial Safety Valve is intended to be used in an Extracorporeal Circuit during cardiopulmonary bypass procedures for the prevention of retrograde flow. TECHNOLOGICAL CHARACTERISTICS/SUBSTANTIAL EQUIVALENCE Quest Medical’s RetroGuard Arterial Safety Valve cleared under K922356 is the predicate device for this submission. At the time of clearance, the predicate device was known as Flow Control Valve, ACV-38 and the premarket application was filed by American Omni Medical, Inc. Quest Medical acquired American Omni in 1993 and the device name was thereafter changed to RetroGuard Arterial Safety Valve. The subject device and the predicate h ave the same indications for use, operating principle, basic design features and are packaged and sterilized using the same materials and processes. There are minor wording differences between the indications for use of the predicate device and the subject device but these differences do not create a new intended use. The overall intended use - preventing retrograde flow remains the same for the predicate and subject device. The first difference in the indications statement is the use of the phrase “intende d to be used in an Extracorporeal Circuit during cardiopulmonary bypass procedures” in the subject device’s indications which seeks to clarify the phrase “indicated for use during extracorporeal procedures” used in the predicate’s indication. This wording change does not introduce any change to the predicate’s intended use, as the predicate device was cleared specifically for use in cardiopulmonary bypass procedures. The other difference is use of the phrase “for the prevention of retrograde flow” in the su bject device’s indication. This phrase, although worded differently, connotes the same meaning as the phrase “ensure that the fluid in the tubing flows in one direction only” used in the predicate’s indication. These minor wording differences in the indica tions for use statement does not change the intended use (prevention of retrograde flow) or raise different questions of safety and effectiveness. The primary differences between the subject device and the predicate are with respect to dimensions, duckbill material and shelf life. The subject device has 1/4” inlet and outlet ports and is smaller than the predicate device which has 3/8” inlet and outlet ports. The material used in the housing and caps for the predicate device and the subject device are identical. The only difference with respect to material is on the duckbill. The material used in the duckbill for the subject device and predicate are both silicone rubber but are sourced from different suppliers. The subject device duckbill is made from an off white silicone rubber which has no colorant and the predicate device duckbill uses a white silicone rubber. The predicate device shelf life is 3 years and the subject device shelf life is 1 year. Overall, the results of functional performance and biocompa tibility testing conducted on the subject device demonstrates that the differences in technological characteristics between the subject device and the predicate do not raise different questions of safety and effectiveness and the subject device is substantially equivalent to the predicate.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 26, 2026